Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: Significant differences in clinical characteristics and prognosis

European Journal of Haematology

Volumn 80, Issue 1, 2008, Pages 55-60

  Lim, Soon Thye ^a   Hee, Siew Wan ^a   Quek, Richard ^a   Lim, Lay Cheng ^b   Yap, Swee Peng ^a   Loong, Er Li ^a   Sng, Ivy ^b   Tan, Leonard Hwan Cheong ^b   Ang, Mei Kim ^a   Ngeow, Joanne ^a   Tham, Chee Kian ^a   Ngo, Lynette ^a   Tan, Min Han ^a   Tao, Miriam ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Characteristics; Extra nodal NK T cell lymphoma; Peripheral T cell lymphoma; Prognosis

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

AGE DISTRIBUTION; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; LYMPHOMA, T-CELL, PERIPHERAL; MALE; NOSE NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 37249046479     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00978.x     Document Type: Article

References (22)

1. Banks PM, Warnke RA. Mature T-cell and NK-cell neoplasms. In : Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Hematopoetic and lymphoid Tissues. Lyon : IARC Press, 2001 : 189 230.
2. Gisselbrecht C, Gaulard P, Lepage E, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 1998 92 : 76 82.
3. Morabito F, Gallamini A, Stelitano C, et al. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi. Cancer 2004 101 : 1601 8.
4. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997 89 : 3909 18.
5. Savage KJ, Chhanabhai M, Gascoyne RD, et al. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004 15 : 1467 75.
6. Xiao C, Su ZL, Wu QL, et al. Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms. Zhonghua Bing Li Xue Za Zhi 2005 34 : 22 7.
7. Yin HF, Li T, Li JX, et al. Retrospective analysis of 304 cases of malignant lymphomas in pathology: study and practice of the WHO classification of lymphoid neoplasms. Zhonghua Yi Xue Za Zhi 2003 83 : 1556 60.
8. Lee MY, Tsou MH, Tan TD, et al. Clinicopathological analysis of T-cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy-type intestinal T-cell lymphoma. Eur J Haematol 2005 75 : 221 6.
9. Spits H, Blom B, Jaleco AC, et al. Early stages in the development of human T, natural killer and thymic dendritic cells. Immunol Rev 1998 165 : 75 86.
10. Rudiger T, Zettl A, Adam P, et al. Peripheral NK/T-cell lymphoma. Pathologie 2007 28 : 55 58.
11. Sukpanichnant S. Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification. Hum Pathol 2004 35 : 224 30.
12. The World Health Organization Classification of Malignant Lymphomas in Japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int 2000 50 : 696 702.
13. Lee SS, Cho KJ, Kim CW, et al. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms. Histopathology 1999 35 : 345 54.
14. Lee MY, Tan TD, Feng AC, et al. Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution. Am J Hematol 2006 81 : 568 75.
15. Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 1998 15 : 83.
16. Au WY, Ma SY, Chim CS, et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol 2005 16 : 206 14.
17. Melnyk A, Rodriguez A, Pugh WC, et al. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 1997 89 : 4514 20.
18. Chim CS, Ma SY, Au WY, et al. Primary nasal natural killer cell lymphoma: Long-term treatment outcome and relationship with the international prognostic index. Blood 2004 103 : 216 21.
19. Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. JCO 2006 24 : 612 8.
20. Vose JM. The International PTCL Project International Peripheral T-Cell Lymphoma (PTCL) Clinical and Pathologic Review Project: poor outcome by prognostic indices and lack of efficacy with anthracyclines. Blood (ASH Annual Meeting Abstracts) 2005 106 : 811.
21. Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999 93 : 3913 21.
22. Au W, Intragumtornchai T, Nakamura S, et al. Clinical and pathological differences between nasal and nasal-type NK/T cell lymphomas: a summary of 136 cases from the International T Cell Lymphoma (ITCL) Project. Blood (ASH Annual Meeting Abstracts) 2006 108 : 292.